Objective. To assess the role of an abnormal immune network in the pathology of IgG4-related disease (IgG4-RD).
Introduction
IgG4-related disease (IgG4-RD) is characterized by hyperimmunoglobulinaemia G4, marked infiltration of IgG4-positive plasma cells into swollen or hypertrophic organs, and fibrosis [1] . Although sensitive to glucocorticoid treatment, the disease has been reported to relapse in nearly half the cases [2] . It is important to elucidate the pathology of this disease and to develop novel treatment strategies for its specific pathological features.
The Comprehensive Diagnostic Criteria for IgG4-RD [3] are commonly used for the diagnosis of IgG4-RD, and are characteristically based on elevated serum IgG4 levels and pathological findings. The histopathological findings include infiltration of lymphocytes and IgG4-positive plasmacytes, along with characteristic fibrosis and sclerosis of tissues [4] . According to the diagnostic criteria, production of antibodies due to excessive immune response and fibrosis are two main pathological features of IgG4-RD. Furthermore, the involvement of human leucocyte antigens such as HLA DRB 1*04:05-DQB1*04:01 and other genetic factors such as FCRL3, CTLA4 and KCNA3 has been suggested especially in autoimmune pancreatitis [5, 6 ], but has not been confirmed in whole IgG4-RD. Familial occurrence has not been reported for this disease. Thus, immunophenotyping in individual cases is important for elucidating the pathology of this disease.
The importance of some immune cells in IgG4-RD has been reported. Oligoclonal expansion of plasmablasts has been reported in IgG4-RD [7] , and this increase is not associated with serum IgG4 levels [8] . We had previously reported that the increased plasmablasts were decreased by glucocorticoid therapy in IgG4-RD [9] . Increased transitional B cells, which are important in germinal centre reactions [10] , may play an important role [11] , although this is controversial [12] . T cells have also been reported to be involved in IgG4-RD. For example, the importance of CD4-positive cytotoxic T cells (CTL) [13, 14] , the involvement of Th2 cells in IgG4-RD cases complicated by atopy [15, 16] , and the involvement of Treg cells [17, 18] and follicular helper T (Tfh) cells including Tfh2 cells and Tfh17 cells [1921] have also been reported. Such studies that elucidate the disease pathology provide theoretical support for novel therapeutic approaches for treating IgG4-RD, such as B cell depletion therapy [22, 23] .
However, because previous studies focused on a single or several immunocompetent cells, the importance of immunocompetent cells in the immune network and their relationships among themselves are unknown. To address this issue, we designed the present study, in which we immunophenotyped T cells, B cells, dendritic cells (DCs), monocytes and natural killer (NK) cells from the peripheral blood of patients with IgG4-RD according to the Human Immunology Project (HIP) Consortium programme established by the National Institute of Allergy and Infectious Diseases [24] . We then assessed the association between immune phenotypes and the disease pathology, and their changes before and after treatment. This is the first report to describe comprehensive immunophenotyping in patients with IgG4-RD.
Methods

Patients
IgG4-RD patients who fullfilled the classfication criteria for IgG4-RD [3] (except for one patient who was diagnosed according to IgG4-related Mikulicz's disease [25] ) were enrolled in this study between April 2013 and 2015. Biopsies were performed and the diagnoses were confirmed in all patients. We also included age-and sexmatched healthy individuals as the control group. The Human Ethics Review Committee of our university reviewed and approved this study, including the collection of peripheral blood samples from the healthy control and IgG4-RD patients. Each subject provided a signed consent form.
Patients' baseline characteristics
The present study included 16 patients with IgG4-RD and 26 healthy controls ( Table 1 ). The mean age of the subjects was 60 years, and 70% were men. The mean disease duration was 1.6 years, while the mean serum IgG level was 2735.5 mg/dl and the mean serum IgG4 level was 693.8 mg/dl. Biopsies were performed and the diagnoses were confirmed in all patients (supplementary Table S1 , available at Rheumatology Online). Further, no statistical differences were observed in the mean age and sex ratio of patients and healthy controls.
Treatment of IgG4-RD
The changes in the immune phenotypes from before and after treatment were assessed in 9 of the 16 patients who participated in the study. All nine patients received glucocorticoid at an initial dose of 0.60.8 mg/kg and the dosages were gradually reduced. One patient received ciclosporin and another patient received MTX. The other 7 of the 16 patients were excluded since they had been followed up without treatment or were transferred to another hospital.
Clinical measurement
Organ involvement was assessed in each patient. To assess the association between disease activity and these immune phenotypes, patients were divided into those with and without extraglandular symptoms (glandular means parotid gland, glandula submandibularis and salivary gland). Laboratory tests including IgG, IgG4 and CRP were also evaluated. Flow cytometric analysis Flow cytometric analysis was performed as previously described [26, 27] . Briefly, peripheral blood mononuclear cells were isolated. Peripheral blood mononuclear cells were resuspended in PBS/3% human IgG (Baxter International Inc., Vienna, Austria) in order to block Fc receptors and prevent non-specific antibody binding, and then incubated for 15 min at 4 C in the dark. Afterwards, the cells were washed with PBS containing 1% bovine serum albumin. Background fluorescence was assessed using appropriate isotype-and fluorochrome-matched control monoclonal antibodies. After staining with the indicated antibodies (supplementary Table S2 , available at Rheumatology Online), cells were analysed by multicolor flow cytometry (FACSVerse; BD Biosciences, San Jose, CA, USA), and were analysed with FlowJo software (Tree Star, Ashland, OR, USA).
Gating strategy of flow cytometric analysis
The phenotype of immune cell subsets was defined based on the HIP protocol of comprehensive eight-colour flow cytometric analysis proposed by National Institutes of Health (NIH)/ the Federation of Clinical Immunology Societies (FOCIS) with some modification for detecting Tfh cells [24] . Details of the gating strategy of flow cytometric analysis are described in supplementary Figs S1 and S2, available at Rheumatology Online. The clones and company names of the antibodies that were used in this study are described in supplementary Table S3 , available at Rheumatology Online.
Immunohistochemical staining
Paraffin-embedded specimens from biopsy were studied by immunohistochemistry to define the presence of positive cells. Anti-Bcl-6 (BioLegend, San Diego, CA, USA) and anti-CD4 (Abcam, Cambridge, UK) were used to define Tfh cells. Expression of both Bcl-6 and CD4 was detected by double-staining, as previously described [28] . Briefly, paraffin-embedded sections were treated in xylene and rehydrated by a gradient of ethanol. For the antigen retrieval, the microwave method was used. Blocking with 5% goat serum (except goat anti-human primary Ab) was performed. Endogenous peroxidase activity was blocked with 3% H 2 O 2 for 30 min. Development of the Bcl-6 Ab with 2,4-diaminobutyric acid (Dako, Santa Clara, CA, USA) was performed first; CD4 Ab was incubated, with binding of secondary AP polymer-conjugated antibody and development with VECTOR Blue (Vector Laboratories, Burlingame, CA, USA). Nuclei were counterstained with haematoxylin (Dako). NanoZoomer digital pathology (Hamamatsu, Shizuoka, Japan), which converts a histology slide into a high-resolution digital slide (190 million pixels), was utilized for analysis. The density of positive cells (per square millimetre) in whole specimen was counted with NanoZoomer Digital Pathology apparatus (Hamamatsu) viewing. To confirm the quality of double staining of CD4 (clone; BC/1F6) and Bcl-6 (clone; IG191E/A8), we performed the following examination. First, the double staining of CD4 and Bcl6 or mouse IgG was performed in human tonsil section. The result was that CD4 positive T cells were around the Bcl-6 positive cell zone (supplementary Fig. S3 , available at Rheumatology Online). Next, double staining of Bcl-6 and CD20 (Abcam, clone; L26) or CD21 (Abcam, clone; EP3093) was performed in the salivary glands. CD20 and Bcl-6 showed a high concordance rate (supplementary Fig. S4A , available at Rheumatology Online). In addition, CD21 positive cells, which were stained in the germinal centre, were also stained by Bcl-6 (supplementary Fig.  S4B , available at Rheumatology Online).
Statistical analysis
Differences between groups were compared using the MannWhitney U test. Correlation analysis was performed using Spearman's rank correlation coefficient. A heat map of the correlation coefficients summarized the pairwise correlative relationships (blue for negative correlation and red for positive correlation), as shown in Fig. 2 . Wilcoxon's signed-rank test was used to detect statistically significant differences between baseline data and those measured at week 52. All reported P-values were two-sided and were not adjusted for multiple testing. The level of significance was set at P < 0.05. All analyses were conducted using JMP v. 11.0 (SAS Institute Inc., Cary, NC, USA) or SPSS Statistics v. 22.0 (IBM Corp., Armonk, NY, USA).
Results
High proportion of plasmablasts, Tfh and Treg cells in IgG4-RD patients Figure 1 shows the overall proportions of the different immune cells by phenotype in the peripheral blood of patients. First, regarding the differentiation of Th cells, the proportion of those in the effector phase, which are considered terminally differentiated effector memory T cells, was significantly higher in patients than in healthy controls (4.6% vs 3.7%). Regarding the differentiation of CTLs, the proportion of central memory CTLs was lower in patients than in healthy controls (7.9% vs 15.3%). The proportions of Th1, Th17, Treg and Tfh cells, which are subsets of Th cells, were also assessed. The proportions of Th1 and Th17 cells in patients were similar to those in healthy controls, whereas the proportions of Treg and Tfh cells in patients were significantly higher than those in healthy controls (5.3% vs 4.0% and 1.5% vs 1.0%, respectively). The proportions of all Treg cell subtypes, activated, naive and memory Treg cells, were higher in patients than in healthy controls.
Regarding the differentiation of B cells, the proportion of IgM memory B cells was lower in patients than in healthy controls (13.1% vs 20.6%), whereas those of classswitched memory B cells was higher (23.7% vs 12.5%). Among all the phenotypes of immunocompetent cells, the proportion of plasmablasts, in particular, characteristically increased to 16.5% in patients, compared with 4.2% in healthy controls (Fig. 1) . Regarding DCs, although no difference was observed in the proportion of plasmacytoid DCs, the proportion of myeloid DCs was lower in patients than in healthy controls (66.9% vs 80.7%). No statistically significant differences were observed in the proportions of NK cells or monocytes. These findings revealed that both T and B cells underwent abnormal differentiation at a higher frequency in patients with IgG4-RD.
Correlation among plasmablasts, Tfh and memory Treg cells Next, the correlations among these immunocompetent cells were assessed. When the correlations were clustered statistically, T and B cell populations at the similar differentiation stage were found to be clustered together ( Fig. 2A) . Furthermore, the proportion of plasmablasts in patients, which was markedly different from that in healthy controls, formed a statistical cluster with the proportion of Tfh cells. The correlations between the T cell subsets (Th1, Th17, Treg and Tfh cells) and the plasmablasts are shown in Fig. 2B . Among the T cell subsets, only Tfh cells were positively correlated with plasmablasts. Other immune phenotypes also showed significant correlations (supplementary Table S4 , available at Rheumatology Online), such as the memory Treg cells, which were correlated with plasmablasts (supplementary Fig. S5 , available at Rheumatology Online).
Proportions of plasmablasts, Tfh and memory Treg cells correlated with disease activity
To determine the association of the plasmablastTfh cell and plasmablastmemory Treg cell axes with clinical
FIG. 1 Differences in immunophenotypes between patients with IgG4-related diseases and sex-matched healthy control subjects
P-values by MannWhitney U-test. The extent of changes, compared with the healthy control, is shown by colour (blue for decrease and red for increase). IgG4-RD, IgG4-related disease.
FIG. 2 The correlation among immune phenotypes
Wilcoxon's signed-rank test for the frequencies of immune cells was perfromed for the differentiation stage classified as the naïve or memory phase or activation status and lineage of functional subsets. (A) The heat maps of the correlation coefficients summarizes the pairwise correlative relationships (blue for negative correlation and red for positive correlation). (B) The correlations between the T cell subsets (Th1, Th17, Treg and Tfh cells) and the plasmablasts. symptoms, the correlations between phenotypes of immune cells in peripheral blood and the clinical signs were assessed.
First, when the correlations of serum IgG and IgG4 levels with immune phenotypes were assessed (supplementary Table S5 , available at Rheumatology Online), the proportions of Tfh cells and plasmablasts were found to be correlated with the serum IgG levels (Fig. 3A) . Likewise, central memory Th cells correlated with both serum IgG levels and IgG4 levels, while naive T helper cells and naive cytotoxic naive T cells negatively correlated with serum IgG levels and IgG4 levels. Despite a lack of significant correlations, plasmablasts tended to be associated with the serum IgG4 levels (Fig. 3A) . In contrast, other Th cell subsets including the memory Treg cells did not show any correlation with serum IgG or IgG4 levels.
Next, to assess the association between disease activity and these immune phenotypes, the subjects were divided into those with and without extraglandular symptoms (supplementary Table S6 , available at Rheumatology Online). The proportions of plasmablasts, Tfh cells and memory Treg cells were found to be significantly increased in patients with extraglandular symptoms (Fig. 3B) .
Circulating Tfh cells reflected the proportion of Tfh in the biopsy site
The results described in the previous sections suggested that plasmablasts and Tfh cells contributed to the production of antibodies in patients with IgG4-RD. Therefore, we examined the association between the Tfh cells in peripheral blood and those that were locally infiltrating.
The Tfh cells were defined as Bcl-6-positive and CD4-positive cells in the histopathological samples (Fig. 4A) ; the number of Tfh cells per unit biopsy area was assessed. The proportions of Tfh cells and activated Tfh cells in the peripheral blood were positively correlated with the area occupied by Tfh cells in the samples biopsied for histopathological examination ( Fig. 4B ; supplementary Table S7 , available at Rheumatology Online). Thus, the phenotype of the immune cells in the peripheral blood likely reflected the local immune responses.
The proportions of plasmabasts and Tfh were decreased after treatment
The changes in the immune phenotypes from before and after treatment were assessed in 9 of the 16 patients who participated in the study. Four patients who had been followed up without treatment and three patients who were transferred to another hospital were excluded.
Glucocorticoid therapy reduced serum IgG4 levels (Fig. 5A ) in all patients, resulting in improved clinical signs. Although no changes were observed in T cell differentiation before and after treatment (supplementary Table S8 , available at Rheumatology Online), the proportions of Th17 and Tfh cells were found to be decreased (Fig. 5B) . However, the proportion of memory Treg cells remained unchanged (Fig. 5B) . In contrast, among the B cell subsets, IgM memory B cells were found to be increased, while plasmablasts were found to be markedly decreased (Fig. 5B) .
Discussion
The importance of some immune cells such as plasmablasts [8] and T cells has been described in basic studies on IgG4-RD. However, because these studies focused on a single or several types of cells, the importance of the immune cells in the overall immune network and the relationships among them are unknown. The present study is the first one to show comprehensive immunophenotyping of T cells, B cells, DCs, monocytes and NK cells in the peripheral blood of patients with IgG4-RD, and the results might help resolve this issue.
Comparing patients and healthy controls, the largest difference was observed in the proportion of plasmablasts. A previous study had reported that increased plasmablast levels could be an indicator for the diagnosis of IgG4-RD [8]; the present study also showed that the proportion of plasmablasts increased remarkably in the peripheral blood. Furthermore, the proportion of plasmablasts was associated with that of Tfh cells, which confirmed the importance of the plasmablastTfh cell axis. In addition, these cells were correlated with serum IgG levels. An important finding from the present study was that the proportion of Tfh cells in the peripheral blood reflected that of the Tfh cells that infiltrated into the actual tissue. In general, Tfh cells enter the follicles in lymph nodes, form the germinal centre with B cells, and induce the differentiation of B cells into plasmablasts. On the other hand, the present study suggested that Tfh cells also form follicular structure in tissues affected by IgG4-RD [19] and stimulate B cells in the germinal centre in lymph nodes to develop pathological features. In fact, the number of plasmablasts tended to be associated with serum IgG4 levels. Based on the assessment of phenotypes of many immune cells mentioned previously, it was assumed that Tfh cells might induce the differentiation of B cells into IgG-or IgG4-producing plasmablasts and play a central role in pathogenesis in tissues affected by IgG4-RD.
Some interesting results were also obtained for Treg cells. Th2 and Treg cells have been considered to be important in the occurrence or pathogenesis of IgG4-RD [29] . In fact, enhanced expression of IL-4, IL-10 and IL-13 in the diseased tissues has been shown [18, 30] . In addition to the cases of IgG4-RD that are complicated by atopy [15] , increased numbers of Th2 and Tfh2 cells in the blood were reported in patients with IgG4-RD [21] . Regarding Treg cells, although increased numbers of CD4-positive CD25 high T cells in autoimmune pancreatitis [31] and Foxp3-positive Treg cells in the salivary glands in Mikulicz's disease [17] have been reported, there is no evidence to indicate the involvement of Treg cells in the pathological features. Furthermore, because of reports on the establishment of Tfh cells in T cell subsets [32] and the reported pathogenesis based on the involvement of mainly Tfh and B cells [20, 33] , the role of Treg cells was not highlighted in the pathogenesis of IgG4-RD. However, the present study showed increased proportions of Treg cells in the peripheral blood of patients with IgG4-RD. When patients were divided based on the presence of extraglandular symptoms, among all the immune phenotypes examined, only memory Treg cells were found to be increased, besides plasmablasts and Tfh cells, as mentioned previously. In addition, the proportion of memory Treg cells did not correlate at all with serum levels of IgG or IgG4, and fluctuated in a pattern different from that of the proportions of Tfh cells and plasmablasts.
These interesting results were observed after treatment. When immune phenotypes before and after treatment were assessed in patients treated with glucocorticoids, the proportions of plasmablasts and Tfh cells were found to be markedly decreased and the clinical features were found to be resolved, whereas the proportion of memory Treg cells remained unchanged. These results indicated that immune phenotypes reflected the two characteristic features of IgG4-RD, that is, production of antibodies (mediated by plasmablasts and Tfh cells) and fibrosis (mediated by TGF-b). In addition, the results indicated an immune response, in which activated Treg cells tried to suppress excessive autoimmune activity in IgG4-RD. Further detailed studies are needed to examine whether the function of Treg cells is impaired in patients with IgG4-RD.
One of the limitations of the present study is the limited sample size, due to the single centre study design. However, definitive diagnosis was made by biopsy in all patients, and we performed this immunophenotyping in all patients before treatment. Because diagnostic accuracy significantly affects the results in studies of such rare diseases, we preferred to conduct this study at a single institution with at least 10 rheumatologists. In addition, because this study was conducted according to the HIP proposed by the National Institute of Allergy and Infectious Disease [24] , the power was too weak to detect trends in the immune phenotypes, apart from the conventional ones. In particular, we could not assess the importance of CD4-positive CTLs in the pathogenesis of IgG4-RD, which has been described recently [13] .
However, the immune phenotypes that had been assessed differently at each institution were standardized in the HIP, and this facilitated the comparison of reports from different institutions and of immune phenotypes by disease. The most difficult aspect of human immunology is to determine whether the finding is a cause or consequence. Although many suggestive phenomena were observed in the present study, they were mostly correlations, beyond which anything is purely speculation. However, as with many other studies, if the therapeutic target molecules are detected, the phenomena observed in the present study may reveal themselves as either causes or consequences. In conclusion, comprehensive immunophenotyping revealed the importance of plasmablasts and Tfh cells in IgG4-RD. Furthermore, the phenotypes of immune cells in the peripheral blood were found to reflect changes in local lesions. The results suggested that Tfh cells induced the differentiation of B cells into plasmablasts and played a major role in the pathogenesis of IgG4-RD. These findings suggested not only that B cell depletion therapy could be theoretically useful, but also that searching for molecules involved in the interaction between Tfh and B cells might lead to the development of future treatment strategies specifically designed for the pathological features of IgG4-RD.
